Lv6
2490 积分 2023-09-18 加入
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
1天前
已完结
Comparative advantage and efficacy of natural products for polycystic ovary syndrome
10天前
已完结
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human
13天前
已完结
Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
13天前
已完结
Primary cervical screening using a universal offer of human papillomavirus self-testing versus usual care in Aotearoa New Zealand: a cluster-randomised, non-inferiority trial
26天前
已关闭
The WHO Pandemic Agreement: protecting pregnant people
26天前
已关闭
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial
26天前
已关闭
Development and validation of a logistic regression model for predicting menstrual irregularity using LDL-C and age in reproductive-aged women: An analysis of NHANES Data
1个月前
已关闭
Combined oral contraceptive use and obesity in women with polycystic ovary syndrome. A meta-analysis of randomized clinical trials
3个月前
已完结
CONSORT 2025 statement: updated guideline for reporting randomised trials
3个月前
已完结
皖公网安备34019202002308
